Injectable T-VEC Offers Hope to Melanoma PatientsInjectable T-VEC Offers Hope to Melanoma Patients
A dual-mechanism immunotherapy based on a genetically modified version of the herpes simplex virus achieves a durable response in melanoma patients. Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Cold Sores | Dermatology | Genetics | Hematology | Herpes | Melanoma | Skin | Skin Cancer